BIOMAKERS FOR CIRCULATING TUMOR CELLS

GENE DEFECTS AND MUTANT ALK KINASE IN HUMAN SOLID TUMORS

Methods of determining need for anti-coagulation therapy

TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS

Methods for Detecting, Diagnosing and Treating Human Renal Cell Carcinoma

ANTIANDROGEN THERAPY MONITORING METHODS AND COMPOSITIONS

Method for assaying sepsis in humans

METHOD OF SCREENING PLACENTAL PROTEINS RESPONSIBLE FOR PATHOPHYSIOLOGY OF PREECLAMPSIA, AND MARKER FOR EARLY DIAGNOSIS AND PREDICTION OF PREECLAMPSIA

Lectin Assay for Assessing Glycoforms as an Early Marker in Disease

Moesin fragments associated with aplastic anemia

SERUM CLUSTERIN LEVELS IN SYSTEMIC AMYLOIDOSIS FEATURING CARDIOMYOPATHY

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

Method for Diagnosis of Bladder Cancer and Related Kits

Wound healing metakaryotic stem cells and methods of use thereof

MATERIALS AND METHODS FOR DIAGNOSING AND PREDICTING THE COURSE OF PROSTATE CANCER

Human B1 cells and uses thereof

DNA encoding an anti-system ASC amino acid transporter 2 (ASCT2) antibody

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

USE OF CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE-ALPHA (CCT-ALPHA) AS A BIOMARKER FOR CANCER PROGNOSIS

DIAGNOSTIC AND PROGNOSTIC ASSAY FOR BREAST CANCER

Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination

DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS

Use of IMP3 as a prognostic marker for cancer

Treatment of circadian rhythm disorders

DIAGNOSTIC AGENT, DIAGNOSTIC METHOD AND THERAPEUTIC AGENT FOR FIBROMYALGIA

DIFFERENTIAL DIAGNOSIS OF PANCREATIC ADENOMAS

Methods and algorithms for aiding in the detection of cancer

Expression of ETS related gene (ERG) and phosphatase and tensin homolog (PTEN) correlates with prostate cancer capsular penetration

Assay for prions

Method and a kit to quantify and qualify exosomes for diagnosis of prostate cancer and prostate hyperplasia

Detection of soluble adiponectin receptor peptides and use in diagnosis and therapeutics

SENSITIVITY AND SPECIFICITY FOR OVARIAN CANCER

In Vitro Tumor Metastasis Model

Use of VAP-1 inhibitors for treating fibrotic conditions

Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment for use in therapy

Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition

Methods and Pharmaceutical Compositions for the Treatment of Bone Density Related Diseases

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF PANCREATIC CANCER

PREDICTIVE BIOMARKER FOR CANCER TREATMENT WITH ADCC-ENHANCED ANTIBODIES

THERAPEUTICS AND PROCESSES FOR TREATMENT OF IMMUNE DISORDERS

T cell receptors and related materials and methods of use

Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration

METHODS OF SELECTING HOST RESISTANT ANIMALS

COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING A PRECURSOR LESION AND/OR ESOPHAGEAL CANCER

METHODS AND COMPOSITIONS RELATING TO PROLIFERATIVE DISORDERS OF THE PROSTATE

METHOD FOR PREDICTING THE RESPONSIVENESS TO CHEMOTHERAPY

METHODS FOR CATEGORISING CANCER SUCH AS BREAST CANCER

Assays for detection of glycosaminoglycans

METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2

METHODS, PRODUCTS AND TREATMENTS FOR DIABETES

Screening methods for transfusion related acute lung injury (TRALI)

ANTIBODIES WITH T-CELL RECEPTOR LIKE SPECIFICITY TOWARDS NATIVE COMPLEXES OF MHC CLASS II AND DIABETES-ASSOCIATED AUTOANTIGENIC PEPTIDES

Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis

Biomarkers for acute ischemic stroke

Detection method for 305 fertility-associated sperm localization proteins expressed in human testis and epididymis

Bladder cancer detection composition, kit and associated methods

Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof

NOVEL BIOMARKERS OF LIVER CANCER

Immunochromatography devices, methods and kits

Biomechanical-based methods of diagnosing scoliosis

METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY

Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis

PROTEIN BIOMARKERS FOR OBSTRUCTIVE AIRWAYS DISEASES

MEANS AND METHODS FOR IDENTIFYING AN INCREASED RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS FOR DEVELOPING RENAL MANIFESTATIONS

G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF PANCREATIC CANCER

Method and kit for detection of autoimmune chronic urticaria

Composition for diagnosing, treating, and preventing liver disease

Predictive markers for taxane responsiveness and methods of use thereof

Methods and Kits for the Diagnosis of Rheumatoid Arthritis

PLATELET BIOMARKERS FOR THE DETECTION OF DISEASE

Methods of determining efficacy of cyclodextrin therapy

EX-VIVO METHOD FOR THE EARLY DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY BY MEANS OF THE DETERMINATION OF THE 3-NITROTYROSINE IN SERUM

DIAGNOSTIC USE OF INDIVIDUAL MOLECULAR FORMS OF A BIOMARKER

Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof

NOVEL THERAPEUTIC TARGET AND DIAGNOSTIC MARKER FOR ASTHMA AND RELATED CONDITIONS

NOVEL C3C EPITOPE, ANTIBODIES BINDING THERETO, AND USE THEREOF

Methods and compositions for treating and diagnosing diseases

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES RELATED CONDITIONS

Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma

Method of diagnosing and treating oxidative stress-impaired wound healing

MARKERS OF ACUTE KIDNEY FAILURE

Diagnostic methods for glaucoma

ASSAY

BLOOD MARKER FOR RENAL CANCER

METHODS OF PROGNOSIS AND DIAGNOSIS OF RHEUMATOID ARTHRITIS

Biomarkers for cancers responsive to modulators of HEC1 activity

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

MULTIPLEX COLON CANCER MARKER PANEL

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

Isolation and application of BAD-1 for diagnosing infections with

Method and system for diagnosis of

PROGNOSTIC TEST OF THE PROGRESSION OF A SOLID TUMOUR BY IMAGE ANALYSIS

KIT FOR MONITORING, DETECTING AND STAGING GVHD

Compositions and methods for detecting, diagnosing, and treating cancer

System for glycated protein detection

Hypercholesterolemia and tendinous injuries

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Methods of determination of activation or inactivation of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof

Immuno-PET imaging of antibodies and immunoconjugates and uses therefor

Marker for Cancer Prognosis and Methods Related Thereto

Diagnostic marker for kidney diseases and use thereof

Insulin-resistance-improving drug

NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES

Compositions and methods for treating cancer and modulating stress granule formation

Therapy for subarachnoid hemorrhage and ischemia

P27KIP1 AS A MOLECULAR MARKER FOR SUITABILITY AND EFFICACY OF TREATMENT WITH HSP27 INHIBITORS

Anti-FDP monoclonal antibody, FDP measurement reagent and reagent kit using same, and FDP measurement method

METHODS AND COMPOSITIONS FOR DIAGNOSIS OF UROSEPSIS AND URINARY TRACT INFECTION

Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation

Detection of soluble adiponectin receptor peptides and use in diagnosis and therapeutics

Biomarkers of hemorrhagic shock

Follistatin-like protein-1 as a biomarker for inflammatory disorders

BARD1 isoforms in lung and colorectal cancer and use thereof

Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm

Biomarkers of lung function

CD36 AS BIOMARKER FOR STEATOSIS

Human Monoclonal Antibodies Against Hendra and Nipah Viruses

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

MST1 AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN HUMAN CANCER

METHOD FOR EARLY PROGNOSIS OF KIDNEY DISEASE

Methods for determining signal transduction activity in tumors

Method, Array and Use Thereof

Methods and compositions for chlamydial antigens as reagents for diagnosis of tubal factor infertility and chlamydial infection

Protein and gene biomarkers for rejection of organ transplants

SOX9 AS A MARKER FOR AGGRESSIVE CANCER

Reagent and reagent kit for measurement of FDP, and measurement method

Methods for the detection and monitoring of acute myocardial infarction

MST1/STK4 PHOSPHO-THREONINE 120 (pMST-T120) ANTIBODY

Mycobacterial antigen composition

Methods for diagnosing cancer and decreasing metastasis by cancer cells

Newly identified colon cancer marker and diagnostic kit using the same

Biomarkers for lymphoma

METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY

Direct or indirect diagnostic test for helminth infection

DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL

Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein

Factor involved in latent infection with herpesvirus, and use thereof

Detection of H5N1 Influenza Infection

MLK4 gene, a new diagnostic and prognostic marker in cancers

Regulatory B cells and their uses

PROTEINS

Method for predicting breast cancer patient response to combination therapy

HISTIDINE RICH PROTEIN-2 DIAGNOSTIC TEST FOR CEREBRAL MALARIA

BIOMARKER SIGNATURES FOR WELLNESS TESTING

BIOMARKER FOR THE DIAGNOSIS, PROGNOSIS AND MONITORING OF CANCER

Markers for acute kidney injury

Markers for renal disease

Cysteine protease Cwp84 (CD2787) as a diagnostic marker for

Methods for diagnosis, prognosis and methods of treatment

METHOD FOR DETECTING GASTRIC CANCER

RECOMBINANT PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEINS 4 AND 5 AND THEIR USE

Perlecan as a biomarker for renal dysfunction

Group B polypeptides, nucleic acids and therapeutic compositions and vaccines thereof

COMPOSITION AND METHODS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LEUKEMIA

Biomarkers for diagnosing liver disease

Methods and compositions for treating cancer

Prediction and recognition of acute kidney injury after surgery

COMPOSITIONS AND METHODS FOR ASSESSING APPENDICITIS

Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome

ASSESSING MAMMALS FOR VASCULAR DISEASES AND VALVULAR DISEASES

Wellness panel

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER

BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOF

Treatment drug for autoimmune diseases and allergic diseases

Salivary Protein Markers for Detection of Breast Cancer

ANTI-MART-1 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE

Lung Cancer Biomarkers and Uses Thereof

Methods and materials for the diagnosis of prostate cancers

Methods and materials for determining the efficacy of prostate cancer therapies

Method and kit for the classification and prognosis of wounds

ACTH for Treatment of Kidney Disease

HISTONE CITRULLINATED PEPTIDES AND USES THEREOF

Methods and devices for diagnosing cardiac disorders

Method of classifying human subjects having adolescent idiopathic scoliosis (AIS) and method for screening for a compound useful in the treatment of AIS and related syndromes causing spinal deformities

METHOD FOR ANALYZING MUCIN 1 HAVING SIAALPHA2-8SIAALPHA2-3GALBETA GLYCANS

Methods for detecting graft-versus-host disease

COLON DISEASE TARGETS AND USES THEREOF

ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT AND PREVENTION OF VASCULAR OR JOINT CAPSULE CALCIFICATION DISORDERS

Methods for diagnosing and assessing risk of developing glomerulosclerosis

Detection of high-risk intraductal papillary mucinous neoplasm and pancreatic adenocarcinoma

USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS

USE OF AN ISOFORM OF HLA-G AS AN OSTEOGENESIS MARKER

ANTI-TRYPANOSOME THERAPEUTIC AND DIAGNOSTIC APPLICATIONS

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF PANCREATIC CANCER

Detection and treatment of LRP4-associated neurotransmission disorders

METHOD FOR EVALUATING ANGIOGENIC POTENTIAL

COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF BREAST AND OVARIAN CANCER

Assessing the risk of a major adverse cardiac event in patients with chest pain

HUMAN LEUCINE-RICH A-2-GLYCOPROTEIN-1 AND AMINOPEPTIDASE N AS RISK INDICATORS FOR CANCER

Endometrial Phase or Endometrial Cancer Biomarkers

METHOD FOR DIAGNOSING KIDNEY DISEASE COMPRISING DETECTING THE LEVEL OF ANNEXIN A2 OR S100A6

S100A4 antibodies and therapeutic uses thereof

BIOMARKER FOR RENAL FUNCTION IN PATIENTS WITH TYPE 2 DIABETES

Methods for detecting a infection

Method of identifying risk for thyroid disorder

IDENTIFICATION OF THE GENE NOTCH3 AS A NOVEL BIOMARKER FOR HUMAN METASTATIC MELANOMA

Genes from 20q13 amplicon and their uses

Antibodies which bind to SCNN1A/TNFRSF1A fusion proteins and methods of use thereof

Assay for measuring inflammatory molecules in orally ingestible samples

Biomarkers for early detection of ovarian cancer

Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same

Cardiovascular Risk Event Prediction and Uses Thereof

DIAGNOSTIC METHODS FOR LIVER DISORDERS

Molecular markers for urinary tract infections

RAPID, SPECIFIC AND SENSITIVE IMMUNOASSAYS FOR THE DETECTION OF HIGHLY VARIABLE GRAM NEGATIVE BACTERIAL ANTIGENS

METHOD TO DETECT TISSUE DEGRADATION LEADING TO INFLAMMATION

Cancer diagnosis by measuring polyisoprenylated methylated protein methyl esterase activity

Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease

BIOMARKERS OF CARDIOVASCULAR DISEASE INCLUDING LRG

TLE3 as a marker for chemotherapy

KIDNEY PROGNOSTIC ASSAY

ANTIBODIES, COMPOSITIONS, AND ASSAYS FOR DETECTION OF CARDIAC DISEASE

Methods for identifying a GLP-1 secretagogue

ANTIBODIES, COMPOSITIONS, AND ASSAYS FOR DETECTION OF CARDIAC DISEASE

Methods for diagnosing and treating an LGI1 related autoimmune disease

USE OF URINARY NGAL TO DIAGNOSE SEPSIS IN VERY LOW BIRTH WEIGHT INFANTS

Immunoassay for quantification of an unstable antigen selected from BNP and proBNP

ENZYMATIC DETERMINATION OF LITHIUM IONS USING PHOSPHOGLUCOMUTASE

Fusion proteins and their use in the diagnosis and treatment of leishmaniasis

METHOD AND BIOMARKER FOR EVALUATING METASTASIS, AND SIRNA COMPOUND FOR INHIBITING METASTASIS

FLC AS BIOMARKER

Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy

Methods of treating diabetes and compositions capable of same

Biomarker to Measure Drug Efficacy in Enteropathic Disease

Kit and Method for Detecting Porous Dental Hydroxyapatite

Method for diagnosing melanocytic proliferations

DIAGNOSTIC METHOD FOR DETECTING ACUTE KIDNEY INJURY USING HEAT SHOCK PROTEIN 72 AS A SENSITIVE BIOMARKER

DIGANOSIS OF A RENAL DISEASE BY OXYGEN AND HYDROGEN ISOTOPES IN A BIOLOGICAL SAMPLE

Composition comprising an angiopoietin-4 fragment

Production of enteritis evoking causal factor by highly pathogenic oral bacteria and high sensitivity detection method therefor

GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF

DETECTION AND MONITORING OF NONALCOHOLIC FATTY LIVER DISEASE

CATALYST AND PROCESS FOR PREPARING ACROLEIN AND/OR ACRYLIC ACID BY DEHYDRATION REACTION OF GLYCERIN

IDENTIFICATION AND USE OF BIOMARKERS FOR DETECTION AND QUANTIFICATION OF THE LEVEL OF RADIATION EXPOSURE IN A BIOLOGICAL SAMPLE

METHODS FOR DIAGNOSIS OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease

Methods of increasing bone mass in a subject comprising inhibiting DKK1

ANTI-INFLAMMATORY FACTORS

Peptide and protein biomarkers for type 1 diabetes mellitus

Methods for identifying and using organ-specific proteins in blood

METHODS AND COMPOSITIONS RELATING TO MULTICILIATE CELL DIFFERENTIATION

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

Microvesicle membrane protein and application thereof

REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS

Material for removing cauxin in cat urine

Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines

LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION

Enzyme Linked Immunosorbent Assay (ELISA) Method and Kit for Detecting Soluble Programmed Cell Death Protein 5 (PDCD5)

Detection kit containing a novel recombinant 15-kDA polypeptide useful for detecting human infection with

Method of diagnosing Sjogren's disease

DETECTION OF NGAL IN CHRONIC RENAL DISEASE

Siglec 15 antibodies in treating bone loss-related disease

Antibody that specifically binds to an epitope in the tureet region of a human Kir channel

Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury

METHOD AND USE FOR ASSESSING RADIATION THERAPY IN ACCORDANCE WITH SAA

Methods for Diagnosis, Prognosis and Methods of Treatment

METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS

SGII AS A PROGNOSTIC MARKER IN CONDITIONS WHICH REQUIRE CRITICAL CARE

INHIBITORS OF GALECTIN-3 AND METHODS OF USE THEREOF

Methods to predict and prevent resistance to taxoid compounds

C-Met receptor regulation by angiotensin IV (AT4) receptor ligands

Lipid biomarkers for stable and unstable heart disease

METHODS OF DIAGNOSING ENDOMETRIOSIS

Salivary Bioassay for Early Detection of Bone Loss

Methods and kit for endometriosis diagnosis

Assay for vascular calcification

Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

Treatment of neuroinflammatory conditions using antibodies directed against MCAM

Methods and compositions to predict and detect acute rejection

Follistatin-like protein-1 as a biomarker for sepsis

Methods for Determining Aged Based Accumulation of Senescent Cells Using Senescense Specific DNA Damage Markers

Methods for detection of biological substances

MICRORNA REGULATING THE INSULIN SIGNALING PATHWAY, AND METHOD FOR SCREENING MATERIAL FOR CONTROLLING THE ACTION OF A TARGET THEREOF

Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs)

Compositions and methods related to S100A12

Methods for Diagnosing The Malignant Potential of Pancreatic Cystic Lesions

NOVEL GENOMIC BIOMARKERS FOR IRRITABLE BOWEL SYNDROME DIAGNOSIS

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

Cystatin C, β2 microglobulin, α1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy

Sepsis blood biomarker system

sCD40L and placental growth factor (PLGF) as biochemical marker combinations in cardiovascular diseases

Use of periostin as a novel biomarker

RNASE 7 AS A MARKER FOR INFECTION

Biomarkers for determining an allograft tolerant phenotype

PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS

Use of cytokine receptors as biomarkers and therapeutic targets in human cancer

Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes

INFORMATION ACQUISITION APPARATUS ON CONCENTRATION OF THIOREDOXINS IN SAMPLE, STRESS LEVEL INFORMATION ACQUISITION APPARATUS AND STRESS LEVEL JUDGING METHOD

Methods for Assessing Tophus Response During Urate Lowering Therapy in Treatment Tophaceous Gout

METHODS FOR THE DIAGNOSIS, RISK ASSESSMENT, AND MONITORING OF AUTISM SPECTRUM DISORDERS

Method for examining acute renal disorder

METHOD FOR IDENTIFYING INCREASED RISK OF ANXIETY DISORDERS